Skip to Content
Merck
  • The administration of oseltamivir results in reduced effector and memory CD8+ T cell responses to influenza and affects protective immunity.

The administration of oseltamivir results in reduced effector and memory CD8+ T cell responses to influenza and affects protective immunity.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology (2014-11-22)
Isabelle Marois, Alexandre Cloutier, Émilie Garneau, Olivier Lesur, Martin V Richter
ABSTRACT

The clinical benefits of oseltamivir (Tamiflu) are well established, but the effects of antiviral treatment on the immune response are poorly understood. By use of flow cytometric analyses and the mouse model, we thoroughly investigated the impact of such a treatment on the immune response and the generation of protective immunity to influenza. We demonstrated that influenza-specific CD8(+) effector T cell recruitment was reduced up to 81% in the lungs of mice treated with oseltamivir (5 or 50 mg/kg twice daily; EC50 49 nM in vitro) compared to saline controls, but cell generation was unaffected in draining lymph nodes. Importantly, we showed that oseltamivir administration significantly decreased the pools of tissue-resident and circulating effector memory (93.7%) and central memory CD8(+) T cells (45%) compared to saline controls. During heterologous secondary infection, a decreased memory CD8(+) T cell pool combined with reduced generation of secondary influenza-specific effectors in the lymph nodes resulted in 10-fold decreased CD8(+) T cell recall responses, which increased mouse morbidity and delayed viral clearance. Furthermore, antiviral administration led to a significant 5.7-fold decreased production of functional anti-influenza antibodies. Thus, our study demonstrates that antiviral treatment affects the development of the adaptive immune response and protective immunity against influenza.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
2,2,2-Tribromoethanol, 97%
SKU
Pack Size
Availability
Price
Quantity
Oseltamivir phosphate (impurity B free), European Pharmacopoeia (EP) Reference Standard
SKU
Pack Size
Availability
Price
Quantity
USP
Oseltamivir phosphate, United States Pharmacopeia (USP) Reference Standard
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Acetyl chloride, reagent grade, 98%
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Acetyl chloride, reagent grade, 98%
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Acetyl chloride, puriss. p.a., ≥99.0% (T)
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Acetyl chloride solution, 1 M in methylene chloride
SKU
Pack Size
Availability
Price
Quantity